mekberg
Member
FTC is currently blocking the acquisition but Illumina is fighting. This is playing out similar to Illumina’s attempted acquisition of Pacific Biosciences.Damn Curt,
Thanks for reminding me. I’m overdue for a colonoscopy myself; and I’m not looking forward to it. Concerning these matters, I’ve been following Graill’s Galleri™, a blood test for the early detection of more than fifty types of cancer. The test has recently completed clinical trials and is purported to be ready in the second quarter of this year.
Grail was to IPO some weeks back, but was purchased by Ilumina for 7.1 billion dollars.
GRAIL Confirms Q2 2021 Introduction of Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test - GRAIL
— PATHFINDER Study Enrollment Completed, Results Expected to Support Galleri Launch — MENLO PARK, Calif., January 11, 2021 – GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today confirmed it expects to introduce Galleri™, its multi-cancer early...grail.com
I’m considering taking a position in Ilumina.